Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
07/2008
07/29/2008US7405209 Protease inhibitors
07/29/2008US7405201 Antibacterial macrocycles
07/29/2008US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
07/29/2008US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma
07/29/2008US7404948 Peptidic conjugates for alopecia prevention and treatment
07/29/2008CA2405486C Method for synthesis of perindopril and its pharmaceutically acceptable salts
07/29/2008CA2203033C Compounds and compositions for delivering active agents
07/24/2008WO2008070141A3 Compositions for delivery of therapeutic agents
07/24/2008WO2008064465B1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan
07/24/2008WO2008033328A3 Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
07/24/2008US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity
07/24/2008US20080177034 Taspase1 and Methods of Use
07/24/2008US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions
07/24/2008US20080177029 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides
07/24/2008US20080176807 Facially amphiphilic polymers and oligomers and uses thereof
07/24/2008US20080176806 Therapeutic uses of tri-, tetra-, penta-, and polypeptides
07/24/2008US20080176792 Vegfr-1 targeting peptides
07/24/2008US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression
07/24/2008CA2675753A1 Substance p and analogs thereof as an immunogenic composition adjuvant
07/24/2008CA2661651A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
07/23/2008EP1947109A2 Biologically active peptides
07/23/2008EP1946110A1 Kokumi-imparting agent
07/23/2008EP1945201A2 Calcium receptor activator
07/23/2008CN101228182A Antibakterielle amid-makrozyklen v
07/23/2008CN101228181A HCV NS3 protease inhibitors
07/23/2008CN101228180A Tripeptides as hepatitis C virus inhibitors
07/23/2008CN101228179A A process for the preparation of perindopril erbumine
07/23/2008CN101228169A Macrocyclic inhibitors of hepatitis c virus
07/23/2008CN101225094A Anthraquinones tetracyclic compound having anticancer activity
07/23/2008CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles
07/23/2008CN100404548C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
07/22/2008US7402663 Obesity, antidiabetic agents
07/22/2008US7402653 Biologically active peptides
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/22/2008US7402586 3-Benzylsulfonylamino-6-methyl-1-[(3-guanidinooxypropyl)aminocarbonylmethyl]-2-pyridinone trifluoroacetate; anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage
07/22/2008US7402561 Of a human papilloma virus-infected cell; topical administration of an oligopeptide halomethyl ketone inhibitor of a chymotrypsin or chymotrypsin-like protease to decrease the amount of viral DNA in the cell; preferred inhibitor is ala-ala-pro-phe chloromethyl ketone
07/22/2008US7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy
07/22/2008US7402322 Human chorionic gonadotrophin, obtained form urine of pregnant humans, used for prophylaxis of allergies, autoimmune disease, graft versus host disease or as antiinflammatory agents; immunotherapy
07/17/2008WO2008086161A1 Macrocyclic hepatitis c protease inhibitors
07/17/2008WO2008085608A1 Compounds and compositions as channel activating protease inhibitors
07/17/2008WO2008083678A2 Pharmaceutically active compounds
07/17/2008US20080171849 Deprotecting peptide from allyl-type protecting groups by palladium catalysis in presence of allyl acceptor; lactamization; solid phase synthesis
07/17/2008US20080171698 A tripeptide mimetic produced by solid phase synthesis on a modified polystrene resin; ACE inhibitors with prolonged activity, improved bioavailability and side effect reduction
07/17/2008US20080171357 Using escherichia as bioreactor for production of empedobacter or sphingobacterium peptide sequences for use in pharmaceutical and foods
07/17/2008DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds
07/17/2008CA2679563A1 Macrocyclic hepatitis c protease inhibitors
07/17/2008CA2675029A1 Pharmaceutically active compounds
07/17/2008CA2673803A1 Compounds and compositions as channel activating protease inhibitors
07/16/2008EP1944610A1 Engineering affinity ligands for macromolecules
07/16/2008EP1943267A1 A process for the preparation of perindopril erbumine
07/16/2008CN101223445A Biomarkers for breast cancer
07/16/2008CN101223187A New peptides useful as dual caspase-2/-6 inhibitors and their biological applications
07/16/2008CN101220338A Glutathione produced bacterial strain and construction method thereof
07/16/2008CN100402549C Bridged bicyclic serine protease inhibitors
07/16/2008CN100402089C Angiotensin-converting enzyme inhibitory peptides
07/15/2008US7399749 For therapy and prophylaxis of disorders associated with the HCV protease
07/15/2008US7399747 Peptides carrying substances across the blood brain barrier
07/15/2008US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides
07/15/2008US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor
07/15/2008CA2315258C Neuroprotective agents
07/15/2008CA2302524C Stable radioiodine conjugates and methods for their synthesis
07/15/2008CA2274149C Peptides and compounds that bind to a receptor
07/15/2008CA2144473C Pna synthesis using a base-labile amino protecting group
07/14/2008CA2677697A1 Pyrimidine substituted macrocyclic hcv inhibitors
07/10/2008WO2008083288A2 Purifiction of romidepsin
07/10/2008WO2008080845A1 Methods for the synthesis of cyclic peptides
07/10/2008WO2008058679A3 Novel amides acting on the adenosine receptors
07/10/2008WO2007133865A3 Hcv/hiv inhibitors an their uses
07/10/2008WO2007117419A3 Methods and compositions relating to post-prolyl cleaving enzyme inhibitors
07/10/2008CA2674309A1 Preparation of romidepsin
07/10/2008CA2673229A1 Methods for the synthesis of cyclic peptides
07/09/2008EP1940470A2 Antibody-drug conjugates and methods of use
07/09/2008EP1590666B1 Compositions and methods for enhancing apoptosis
07/09/2008EP1338604B9 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres
07/09/2008CN101215544A Inflammation-inhibiting compounds
07/09/2008CN101214380A Method and carrier complexes for delivering molecules to cells
07/08/2008US7396906 Pro4399 Polypeptides
07/08/2008US7396859 Perturbed membrane-binding compounds
07/08/2008US7396846 Growth hormone secretagogues
07/08/2008US7396814 Metallopeptide compositions for treatment of sexual dysfunction
07/08/2008US7396812 Administering muramyl tripeptide or a derivative to enhance immune response; particularly for treating gramnegative bacterial infections
07/08/2008US7396665 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease
07/08/2008CA2372377C A novel inhibitor of beta amyloid cleavage enzyme
07/08/2008CA2250712C Chimeric isoprenoid synthases and uses thereof
07/03/2008WO2008077194A1 Receptor agonists
07/03/2008WO2008060927A3 Hepatitis c virus inhibitors
07/03/2008WO2008060927A2 Hepatitis c virus inhibitors
07/03/2008WO2008027162A3 129xe biosensors and their use
07/03/2008WO2008010930A3 Hiv-1 peptides, nucleic acids, and compositions, and uses thereof
07/03/2008WO2007147165A3 Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof
07/03/2008US20080160501 Plasma protein-binding ligands
07/02/2008EP1939297A1 Alzheimer's disease secretase
07/02/2008EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
07/02/2008EP1938832A1 Angiotensin-converting enzyme inhibitory peptides
07/02/2008EP1937708A1 Asymmetric synthesis of peptides
07/02/2008EP1937634A1 Cathepsin cysteine protease inhibitors
07/02/2008EP1756142B1 Pseudopeptides growth hormone secretagogues
07/02/2008EP1633702B1 Protease inhibitors
07/02/2008EP1451181B1 Dimeric compounds and their use as anti-viral agents
07/02/2008CN100398661C Casein hydrolyzate, process for producing the same and use thereof
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 307